FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy.
Eur J Heart Fail
; 14(5): 549-62, 2012 May.
Article
in En
| MEDLINE
| ID: mdl-22417655
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Caffeic Acids
/
Myocytes, Cardiac
/
Diabetes Mellitus, Experimental
/
Diabetic Cardiomyopathies
/
Ortho-Aminobenzoates
/
Heart Failure
/
Myocardium
/
Antifibrinolytic Agents
Type of study:
Etiology_studies
Limits:
Animals
Language:
En
Journal:
Eur J Heart Fail
Journal subject:
CARDIOLOGIA
Year:
2012
Document type:
Article
Affiliation country:
Australia